A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents.

By M. Babapulle, L. Joseph, P. Belisle, J. Brophy, M. Eisenberg. The Lancet, 2004

693 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. (2005, background): “Thus, not all Paclitaxel-eluting stents are equal.(383,384) Sirolimus has been clinically tested only by being eluted from a polymer carrier, like in the SIRIUS trial(385) (Table 16 ).”
Triggers, targets and treatments for thrombosis (2008, background): “The drugs are designed to prevent smooth muscle cell proliferation and intimal hyperplasia, which lead to re-occlusion of the vessel (that is, to restenosis), and randomized clinical trials have shown that drug-eluting stents reduce the rate of restenosis compared with bare metal stent”